Please feel free to forward to fellow researchers and share news of our journal | Dear Colleague, We are delighted to announce the publication of Volume 6, Issue 2 of our Kidney Cancer journal. This issue includes an article commentary on evaluating the optimal duration of immunotherapy in kidney cancer, plus two review articles, a brief report, and three systematic reviews. From the editor of our regular journal section, there is also a new Clinical Trials Corner contribution. View all the open access content via the links below. | Call for Papers As a member of our community, we would like to invite you to submit your own research articles to the journal, which offers contributing authors many benefits: • First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• The first volumes of the journal are freely available to all readers
• Articles accepted this year will be published open access with no article processing fee Submit your manuscript online via Editorial Manager
View detailed Instructions to Authors
Aims and Scope Kidney Cancer is an international, multidisciplinary journal that provides an invaluable and indispensable platform for the many collaborative, transdisciplinary, and translational efforts to help treat and finally cure this malignancy. Best wishes, Primo N. Lara Jr, MD
UC Davis Comprehensive Cancer Center
Sacramento, CA, USA
Email: kca@iospress.com Peter Mulders, MD, PhD
Radboud UMC
Nijmegen, The Netherlands
Email: kca@iospress.com Editors-in-Chief
Sign up now for Kidney Cancer news
Join the conversation at: twitter.com/KCA_Journal | All articles are freely available online for all to read, download and share. Review Articles
Hereditary Renal Cell Carcinoma – Open Access
Dawsey, Scott J. | Gupta, Shilpa What We Have Learnt from CARMENA and SURTIME and What Should Be Done Differently in Future Trials on Cytoreductive Nephrectomy – Open Access
Zondervan, Patricia J. | Bex, Axel Article Commentary
Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer – Open Access
Parikh, Mamta | Lara, Primo N. Brief Report
Immune Gene Signature Expression Differs between African American and Caucasian Patients with Renal Cell Carcinoma – Open Access
Ghatalia, Pooja | Shah, Aangi | Slifker, Michael Systematic Reviews
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer – Open Access
Palma dos Reis, Ana F. | Simão, Diana | Odeny, Thomas | Rodrigues, Chiara | Fontes-Sousa, Mário | da Luz, Ricardo | Chowdry, Rajasree P. | Welsh, Sarah J. | Paller, Channing | Barata, Pedro C. Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review – Open Access
Gonçalves, Vinicius Knackfuss | Monteiro, Fernando Sabino Marques | Gazola, Antonia Angeli | Pizzolo, Felipe | Hübner, Júlia Elisa | Pellegrini, Rodrigo | Borba, Alessandra | Fay, André P. The Current Status of Kidney Cancer Urine Markers – A Systematic Review – Open Access
Köditz, Barbara | Heidenreich, Axel | von Brandenstein, Melanie Clinical Trials Corner
Clinical Trials Corner: Adding up in Adjuvant – Open Access
Parikh, Mamta | Most Viewed Kidney Cancer Articles in Q2 2022 Listing articles published in 2021 and 2022 so you can read the most popular recent content Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma ( Case Report in Vol.6, Iss.1, 2022) – Open Access
Sharma, Akanksha | Elias, Roy | Christie, Alana | Williams, Noelle S. | Pedrosa, Ivan | Bjarnason, Georg A. | Brugarolas, James Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma (Systematic Review in Vol.6, Iss.1, 2022) – Open Access
Brown, Jason R. | Calaway, Adam | Castle, Erik | Garcia, Jorge | Barata, Pedro C. “PROBE”ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer (Review Article in Vol.6, Iss.1, 2022) – Open Access
Bell, Hannah | Cotta, Brittney H. | Salami, Simpa S. | Kim, Hyung | Vaishampayan, Ulka Patient-Derived Renal Cell Carcinoma Xenografts Capture Tumor Genetic Profiles and Aggressive Behaviors (Research Article in Vol.6, Iss.1, 2022) – Open Access
Beserra, Adriano O. | Estevan, Ethiene C. | Bezerra, Stephania M. | Torrezan, Giovana T. | Ikegami, Amanda | Dellê, Humberto | Cunha, Isabela W. | Meira, Isabella T. | Carraro, Dirce M. | Lara Jr., Primo N. | Zequi, Stenio C. | Martins, Vilma R. | Santos, Tiago G. Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions (Review Article in Vol.5, Iss.1, 2021) – Open Access
Kazarian, Austin G. | Chawla, Neal S. | Muddasani, Ramya | Pal, Sumanta K. | Kidney Cancer Association News Austin, TX, USA & Virtual | November 4–5, 2022 The International Kidney Cancer Symposium: North America is an important meeting held each fall by the Kidney Cancer Association. This year it is back as an in-person event – with the option to join virtually as well – and will be an opportunity for physicians, researchers, academics, and industry professionals from across the globe to join together and exchange ideas which will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure. The 2022 event takes place in Austin, Texas over the course of two days, Novemiber 4 and 5, 2022. Registration is open and you can find program details online. | Register your place now via the event website here | Please Share Kidney Cancer News With Your Colleagues Help Spread the News! | If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here. Kidney Cancer has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter? Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from Kidney Cancer.
You can unsubscibe or alter your preferences at any time by clicking the links below. | |
